Gov. Maura Healey says she’ll vote no on Question 8, the repeal bid targeting Massachusetts’ adult-use market, as polling shows 71% opposition and top Democrats urge voters to keep cannabis legal.

A University of Michigan–led analysis reported in Annals of Internal Medicine finds a 16% rise since 2020 in U.S. clinicians authorizing medical cannabis, with millions of patients participating.

Oregon pauses a proposed psilocybin fee increase, California earmarks $4.7M for psychedelic research, and the DEA moves to schedule five tryptamines—here’s why it matters.

Florida advocates are regrouping after a 2024 setback, aiming to place adult-use cannabis on the 2026 ballot. Here’s what’s known, what’s not, and why DMV readers should care.

Rescheduling momentum is real, but tax experts say cannabis businesses may remain under 280E for the entire 2025 tax year. Here’s what that means for DMV operators and delivery services.

A DEA administrative law judge issued a stay on the wider adult-use rescheduling review, weighing a GAO report’s admission and extra briefing. The pause does not alter April’s medical marijuana move to Schedule III, per mg Magazine.

In a unanimous move, Portland will make personal, non-commercial use and sharing of natural psychedelics a low police priority—without legalizing sales or impaired driving.

MJBizDaily flags a core risk: without uniform, reliable products, future interstate cannabis commerce—and compliant delivery—will stumble. Here’s what it means for the DMV.

Psychedelic Alpha flagged a busy “Psychedelics Week” in DC with multiple meetings. Here’s what that activity could signal for policy, access, and the DMV community.

A new University of New Hampshire survey finds strong, bipartisan opposition to a Massachusetts ballot push to end adult-use cannabis—offering clues for policy watchers in the DMV.

Ohio hemp businesses say adult-use enforcement creates a two-tier system favoring licensed marijuana dispensaries. Regulators counter that the 2023 voter-approved statute regulates marijuana—not hemp.

Canada and Germany remain the hubs of international cannabis trade, but supply routes are changing fast—reshaping pricing, logistics, and delivery investments.

A one‑month reprieve pushes a federal hemp ban to December, sharpening tensions between hemp and cannabis advocates—and raising delivery compliance questions across the DMV.

Marijuana Venture reports a hands-on hempcrete workshop outside Santa Cruz on August 22–23. Here’s why the training matters and what DMV readers should watch next.

An editor’s road trip through Southeast Washington stores sparks a bigger conversation: how retail reality, delivery rules, and compliance shape customer trust in the DMV.

NORML’s new op-ed challenges The New York Times’ framing of cannabis. Here’s why that media narrative matters for delivery rules, licensing, and consumer safety in the DMV.

Alabama health officials unanimously withdrew their objection to potential federal rescheduling of medical cannabis, while the state program continues despite cannabis remaining Schedule I under Alabama law.

A new Elon University poll shows strong support in North Carolina for medical cannabis and a narrow majority for adult-use. Here’s what it could mean for delivery, policing, and the DMV.

A new Psychedelic Alpha podcast surveys D.C.’s psychedelic moment, the FDA’s evolving medical framework, and New Zealand’s MDMA prescribers—here’s why the DMV should care.

Inside RIPS on Maui, a six‑day gathering where death doulas, clinicians, and caregivers explore lineage‑rooted, psychedelic‑informed end‑of‑life care—and what it could mean for the DMV.